142 related articles for article (PubMed ID: 9218728)
21. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.
Roncella S; Ferro P; Bacigalupo B; Pronzato P; Tognoni A; Falco E; Gianquinto D; Ansaldo V; Dessanti P; Fais F; Rosai J; Fedeli F
J Exp Clin Cancer Res; 2005 Jun; 24(2):265-71. PubMed ID: 16110760
[TBL] [Abstract][Full Text] [Related]
22. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease.
Mori M; Mimori K; Ueo H; Karimine N; Barnard GF; Sugimachi K; Akiyoshi T
Int J Cancer; 1996 Dec; 68(6):739-43. PubMed ID: 8980176
[TBL] [Abstract][Full Text] [Related]
23. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
[TBL] [Abstract][Full Text] [Related]
24. Detection of tumour cells in peripheral blood and bone marrow from Ewing tumour patients by RT-PCR.
Pfleiderer C; Zoubek A; Gruber B; Kronberger M; Ambros PF; Lion T; Fink FM; Gadner H; Kovar H
Int J Cancer; 1995 Apr; 64(2):135-9. PubMed ID: 7542227
[TBL] [Abstract][Full Text] [Related]
25. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
26. Detection of occult tumour cells in bone marrow and blood in breast cancer patients--methods and clinical significance.
Kvalheim G
Acta Oncol; 1996; 35 Suppl 8():13-8. PubMed ID: 9073044
[TBL] [Abstract][Full Text] [Related]
27. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.
Wong IH; Leung T; Ho S; Lau WY; Chan M; Johnson PJ
Br J Cancer; 1997; 76(5):628-33. PubMed ID: 9303362
[TBL] [Abstract][Full Text] [Related]
28. Ep-CAM--a marker for the detection of disseminated tumor cells in patients suffering from SCCHN.
Chaubal S; Wollenberg B; Kastenbauer E; Zeidler R
Anticancer Res; 1999; 19(3B):2237-42. PubMed ID: 10472336
[TBL] [Abstract][Full Text] [Related]
29. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
30. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.
Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A
J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
32. Evaluating GA733-2 mRNA as a marker for the detection of micrometastatic breast cancer in peripheral blood and bone marrow.
Zhong XY; Kaul S; Eichler A; Bastert G
Arch Gynecol Obstet; 1999 Nov; 263(1-2):2-6. PubMed ID: 10728619
[TBL] [Abstract][Full Text] [Related]
33. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
[TBL] [Abstract][Full Text] [Related]
34. Detection of bone marrow-disseminated breast cancer cells using an RT-PCR assay of MUC5B mRNA.
Berois N; Varangot M; Sóñora C; Zarantonelli L; Pressa C; Laviña R; Rodríguez JL; Delgado F; Porchet N; Aubert JP; Osinaga E
Int J Cancer; 2003 Feb; 103(4):550-5. PubMed ID: 12478674
[TBL] [Abstract][Full Text] [Related]
35. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
[TBL] [Abstract][Full Text] [Related]
36. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C
Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386
[TBL] [Abstract][Full Text] [Related]
37. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.
De Luca A; Pignata S; Casamassimi A; D'Antonio A; Gridelli C; Rossi A; Cremona F; Parisi V; De Matteis A; Normanno N
Clin Cancer Res; 2000 Apr; 6(4):1439-44. PubMed ID: 10778975
[TBL] [Abstract][Full Text] [Related]
38. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction.
Jonas S; Windeatt S; O-Boateng A; Fordy C; Allen-Mersh TG
Gut; 1996 Nov; 39(5):717-21. PubMed ID: 9014772
[TBL] [Abstract][Full Text] [Related]
39. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
40. Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry.
López-Guerrero JA; Gilabert PB; González EB; Sanz Alonso MA; Pérez JP; Talens AS; Oraval EA; de la Rubia Comos J; Boix SB
J Hematother; 1999 Feb; 8(1):53-61. PubMed ID: 10192302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
